LGND - Ligand Pharmaceuticals - Stock Forecast

Healthcare - Sector
Coverage Stock analysts Price Targets & Ratings Chart Insider Trading

LGND is currently covered by 9 analysts with an average price target of $309.31. This is a potential upside of $7.5 (2.49%) from yesterday's end of day stock price of $301.81.

Ligand Pharmaceuticals's activity chart (see below) currently has 230 price targets and 180 ratings on display. The stock rating distribution of LGND is 100% BUY.

Stock Analyst Price Targets - Review

Analysts average stock forecasts to be materialized ratio is 92.76% with an average time for these price targets to be met of 365.71 days.

Highest price target for LGND is $397, Lowest price target is $220, average price target is $309.31.

Most recent stock forecast was given by JOSEPH PANTGINIS from HC WAINWRIGHT on 24-Sep-2026. First documented stock forecast 12-Feb-2014.

Best performing analysts who are covering LGND - Ligand Pharmaceuticals:

Yigal Nochomovitz Joseph Pantginis Matt Hewitt Trevor Allred Scott Henry Balaji Prasad

Currently out of the existing stock ratings of LGND, 30 are a BUY (100%).

Analyst name

Rating

Current price target

Potential Upside

Previous price target

Date of last PT

Price targets met ratio

Average potential upside

Average Days to Hit Target

Performance score

Buy Since 12-Feb-2014

$358

$56.19 (18.62%)

$358

18 days ago
(24-Sep-2026)

58/60 (96.67%)

$58.96 (19.72%)

683

Buy Since 24-Mar-2026

$397

$95.19 (31.54%)

$387

19 days ago
(23-Sep-2026)

2/4 (50%)

$98.59 (33.04%)

81

Buy Since 30-Jul-2024

$345

$43.19 (14.31%)

$340

2 months 5 days ago
(07-Aug-2026)

11/13 (84.62%)

$51.85 (17.69%)

211

Buy Since 03-Oct-2024

$326

$24.19 (8.01%)

$147

2 months 9 days ago
(03-Aug-2026)

2/3 (66.67%)

$33.96 (11.63%)

280

Buy Since 11-Mar-2026

$388

$86.19 (28.56%)

$260

3 months 3 days ago
(09-Jul-2026)

3/4 (75%)

$65.39 (20.27%)

67

Show more analysts

Please expand the browser size to see the chart

What is LGND (Ligand Pharmaceuticals) average time for price targets to be met?

On average it took 366 days for the stock forecasts to be reached, with an average price target met ratio of 92.76%.

Which analyst most recently updated their price target on LGND (Ligand Pharmaceuticals)?

Joseph Pantginis

Which analyst has the most public recommendations on LGND (Ligand Pharmaceuticals)?

Joseph Pantginis has 37 price targets and 30 ratings on LGND

Which analyst is the currently most bullish on LGND (Ligand Pharmaceuticals)?

Yigal Nochomovitz with the highest potential upside of $95.19

Which analyst is the currently most reserved on LGND (Ligand Pharmaceuticals)?

Jacob Johnson with the lowest potential downside of -$251.22
✖

To continue looking at which analysts cover the stock please register to the basic or advanced membership

To continue looking at analysts data please register to the advanced membership

What is AnaChart?